Skip to main content
Feature Article

Blood Management in Total Knee Arthroplasty: A Comparison of Techniques

    Orthopedics, 2009;32(1):1–8
    Published Online:https://doi.org/10.3928/01477447-20090101-21Cited by:32

    Abstract

    Patients undergoing total knee arthroplasty (TKA) are at high risk for postoperative anemia and allogeneic blood transfusions. Risks associated with allogeneic blood exposure (ie, infection, fluid overload, and longer hospital stays) have prompted alternative blood management strategies. The main goal of this study was to evaluate whether a single change in the clinical blood management of patients undergoing TKA reduced the severity of postoperative anemia or the need for allogeneic blood transfusions. A second goal of this study was to assess the financial impact of the change on the institution. This study compared perioperative cell salvage, preoperative autologous blood donation, and the practice of using allogeneic blood alone in patients undergoing TKA. Clinical and financial data of 154 unique cases of primary TKA at the Mayo Clinic Arizona were retrospectively reviewed. Transfusion rates were 25%, 18%, and 52% respectively for patients in the cell salvage, preoperative autologous blood donation, and allogeneic blood only groups. Respective relative risk reductions were 51.9% (P=.007) and 65.4% (P=.002) with the use of cell salvage or preoperative autologous blood donation versus allogeneic alone. Cell salvage and preoperative autologous blood donation were found to significantly reduce the requirements for allogeneic blood transfusions; these techniques were found to be roughly equivalent in clinical benefit when compared to the use of allogeneic blood alone. The logistical advantages of cell salvage (ie, no preoperative blood donation, no risk of wasting blood units) were associated with greater costs to the institution.

    • 1.Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am. 1999; 81(1):2–10.

      > Crossref MedlineGoogle Scholar
    • 2.Carrero A, Del Monte Trujillo M, Munoz M. Postoperative washed red cell reinfusion reduces allogeneic transfusion requirements after total knee replacement. Transfusion Alternatives in Transfusion Medicine. 2006; 8(4):203–209.

      > CrossrefGoogle Scholar
    • 3.Cushner FD, Hawes T, Kessler D, Hill K, Scuderi GR. Orthopaedic-induced anemia: the fallacy of autologous donation programs. Clin Orthop Relat Res. 2005; ( 431):145–149.

      > CrossrefGoogle Scholar
    • 4.Friederichs MG, Mariani EM, Bourne MH. Perioperative blood salvage as an alternative to predonating blood for primary total knee and hip arthroplasty. J Arthroplasty. 2002; 17(3):298–303.

      > Crossref MedlineGoogle Scholar
    • 5.Guerra JJ, Cuckler JM. Cost effectiveness of intraoperative autotransfusion in total hip arthroplasty surgery. Clin Orthop Relat Res. 1995; ( 315):212–222.

      > Google Scholar
    • 6.Jain R, Jain S. Blood salvage in total hip and knee arthroplasty in a community hospital: a retrospective study. J Orthop Surg (Hong Kong). 2005; 13(1):19–26.

      > Crossref MedlineGoogle Scholar
    • 7.Keating EM, Ritter MA. Transfusion options in total joint arthroplasty. J Arthroplasty. 2002; 17(4 suppl 1):125–128.

      > Crossref MedlineGoogle Scholar
    • 8.Kourtzis N, Pafilas D, Kasimatis G. Blood saving protocol in elective total knee arthroplasty. Am J Surg. 2004; 187(2):261–267.

      > Crossref MedlineGoogle Scholar
    • 9.Moonen AF, Knoors NT, van Os JJ, Verburg AD, Pilot P. Retransfusion of filtered shed blood in primary total hip and knee arthroplasty: a prospective randomized clinical trial. Transfusion. 2007; 47(3):379–384.

      > Crossref MedlineGoogle Scholar
    • 10.Napolitano LM. Perioperative anemia. Surg Clin North Am. 2005; 85(6):1215–1227, x.

      > Crossref MedlineGoogle Scholar
    • 11.Sculco TP. Global blood management in orthopaedic surgery. Clin Orthop Relat Res. 1998; ( 357):43–49.

      > CrossrefGoogle Scholar
    • 12.Tobias JD. Strategies for minimizing blood loss in orthopedic surgery. Semin Hematol. 2004; 41(1 suppl 1):145–156.

      > Crossref MedlineGoogle Scholar
    • 13.Blajchman MA, Vamvakas EC. The continuing risk of transfusion-transmitted infections. N Engl J Med. 2006; 355(13):1303–1305.

      > Crossref MedlineGoogle Scholar
    • 14.Borghi B, van Oven H. Reducing the risk of allogeneic blood transfusion. CMAJ. 2002; 166(3):332–334.

      > MedlineGoogle Scholar
    • 15.Clark CR, Spratt KF, Blondin M, Craig S, Fink L. Perioperative autotransfusion in total hip and knee arthroplasty. J Arthroplasty. 2006; 21(1):23–35.

      > Crossref MedlineGoogle Scholar
    • 16.Huet C, Salmi LR, Fergusson D, Koopmanvan Gemert AW, Rubens F, Laupacis A. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators. Anesth Analg. 1999; 89(4):861–869.

      > MedlineGoogle Scholar
    • 17.Vamvakas EC. Possible mechanisms of allogeneic blood transfusion-associated postoperative infection. Transfus Med Rev. 2002; 16(2):144–160.

      > Crossref MedlineGoogle Scholar
    • 18.Woolson ST, Wall WW. Autologous blood transfusion after total knee arthroplasty: a randomized, prospective study comparing predonated and postoperative salvage blood. J Arthroplasty. 2003; 18(3):243–249.

      > Crossref MedlineGoogle Scholar
    • 19.Munoz M, Campos A, Munoz E, Carrero A, Cuenca J, Garcia-Erce JA. Red cell salvage in orthopedic surgery. Transfusion Alternatives in Transfusion Medicine. 2006; 8(1):41–51.

      > CrossrefGoogle Scholar
    • 20.Garvin KL, Feschuk CA, Sekundiak TD, Lyden ER. Blood salvage and allogenic transfusion needs in revision hip arthroplasty. Clin Orthop Relat Res. 2005; ( 441):205–209.

      > Crossref MedlineGoogle Scholar
    • 21.Orpen NM, Little C, Walker G, Crawfurd EJ. Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients. Knee. 2006; 13(2):106–110.

      > Crossref MedlineGoogle Scholar
    • 22.Sutton PM, Cresswell T, Livesey JP, Speed K, Bagga T. Treatment of anaemia after joint replacement. A double-blind, randomised, controlled trial of ferrous sulphate versus placebo. J Bone Joint Surg Br. 2004; 86(1):31–33.

      > Crossref MedlineGoogle Scholar
    • 23.Weber EW, Slappendel R, Hemon Yet al.. Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST). Eur J Anaesthesiol. 2005; 22(4):249–257.

      > Crossref MedlineGoogle Scholar
    • 24.Carless PA, Henry DA, Moxey AJet al.. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2006; (4):CD001888.

      > MedlineGoogle Scholar
    • 25.Guerin S, Collins C, Kapoor H, McClean I, Collins D. Blood transfusion requirement prediction in patients undergoing primary total hip and knee arthroplasty. Transfus Med. 2007; 17(1):37–43.

      > Crossref MedlineGoogle Scholar
    • 26.Klein HG. Allogeneic transfusion risks in the surgical patient. Am J Surg. 1995; 170(6A suppl):21S–26S.

      > Crossref MedlineGoogle Scholar
    • 27.Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood. 2001; 97(5):1180–1195.

      > Crossref MedlineGoogle Scholar
    • 28.Vamvakas EC. White-blood-cell-containing allogeneic blood transfusion, postoperative infection and mortality: a meta-analysis of observational ‘before-and-after’ studies. Vox Sang. 2004; 86(2):111–119.

      > Crossref MedlineGoogle Scholar
    • 29.Vamvakas EC. White-blood-cell-containing allogeneic blood transfusion and postoperative infection or mortality: an updated meta-analysis. Vox Sang. 2007; 92(3):224–232.

      > Crossref MedlineGoogle Scholar
    • 30.Innerhofer P, Klingler A, Klimmer C, Fries D, Nussbaumer W. Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty. Transfusion. 2005; 45(1):103–110.

      > Crossref MedlineGoogle Scholar
    • 31.Karger R, Weber C, Schmidt J, Kretschmer V. Characterization of immune system alterations following preoperative autologous blood donation for elective hip replacement surgery. Transfus Med. 2007; 17(1):45–53.

      > Crossref MedlineGoogle Scholar
    • 32.Carless P, Moxey A, O'Connell D, Henry D. Autologous transfusion techniques: a systematic review of their efficacy. Transfus Med. 2004; 14(2):123–144.

      > Crossref MedlineGoogle Scholar

    We use cookies on this site to enhance your user experience. For a complete overview of all the cookies used, please see our privacy policy.

    ×